Qunfang Zhang

Guangzhou, 510006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy.

Tumor organoids targeted by receptor-engineered immune cells: A promising approach for advancing cancer immunotherapy.

Journal: International immunopharmacology
Published: July 14, 2025

Astragalus polysaccharide enhances antitumoral effects of chimeric antigen receptor- engineered (CAR) T cells by increasing CD122+CXCR3+PD-1- memory T cells.

Astragalus polysaccharide enhances antitumoral effects of chimeric antigen receptor- engineered (CAR) T cells by increasing CD122+CXCR3+PD-1- memory T cells.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 27, 2024

Methotrexate and electrostimulation cooperate to alleviate the relapse of psoriasiform skin inflammation by suppressing memory T cells.

Methotrexate and electrostimulation cooperate to alleviate the relapse of psoriasiform skin inflammation by suppressing memory T cells.

Journal: Biochemical pharmacology
Published: September 07, 2023

MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I.

MiR-124-3p mediates gastric cancer cell ferroptosis induced by an anti-cancer drug polyphyllin I.

Journal: Frontiers in pharmacology
Published: August 30, 2023

The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells.

The TOPK Inhibitor HI-TOPK-032 Enhances CAR T-cell Therapy of Hepatocellular Carcinoma by Upregulating Memory T Cells.

Journal: Cancer immunology research
Published: July 20, 2023

Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.

Corrigendum: Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.

Journal: Frontiers in pharmacology
Published: April 07, 2023

Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.

Polyphyllin I suppresses the gastric cancer growth by promoting cancer cell ferroptosis.

Journal: Frontiers in pharmacology
Published: January 16, 2023

Retraction: A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection.

Retraction: A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: December 05, 2022

Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling.

Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling.

Journal: Frontiers in immunology
Published: March 20, 2021

Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota.

Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8+ T-Cells Through Altering the Gut Microbiota.

Journal: Frontiers in immunology
Published: December 28, 2020

Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma.

Resveratrol exerts antitumor effects by downregulating CD8+CD122+ Tregs in murine hepatocellular carcinoma.

Journal: Oncoimmunology
Published: November 05, 2020

Paeoniflorin ameliorates murine lupus nephritis by increasing CD4+Foxp3+ Treg cells via enhancing mTNFα-TNFR2 pathway.

Paeoniflorin ameliorates murine lupus nephritis by increasing CD4+Foxp3+ Treg cells via enhancing mTNFα-TNFR2 pathway.

Journal: Biochemical pharmacology
Published: November 03, 2020
Showing 1-12 of 20

Last Updated: 09/26/2026